Meet us at these European research events in 2018


Find out more

Our Mission

As a unique alliance of NGOs and healthcare companies, EURADIA’s mission is to improve the lives of people affected by diabetes both now and in the future, through advocacy of diabetes research in Europe at the highest political and societal levels of influence, by improving coordination of European diabetes research and by shaping the allocation of resources for such research through increased awareness.

What is EURADIA

Who we are: EURADIA is an alliance of non-governmental organisations (NGOs) and healthcare companies working for diabetes research. The NGOs include European academic and clinical researchers, healthcare professionals and patient groups.

What we do: We provide a platform for all those undertaking research to work together to benefit the wellbeing of people with diabetes, through advocacy for increased funding and improved coordination of diabetes research in Europe.

A Brief History of EURADIA

EURADIA began in 2003 as a collaboration of NGOs and healthcare companies with an interest in supporting and promoting diabetes research at European Level.

This successful collaboration has grown in number of stakeholders and has a Secretariat based in the UK.

EURADIA is an independent charity registered with the Charity Commission for England and Wales.


Today is National Walk to work day.
Leave your car keys at home and get some fresh air into your lungs.
Did you know that it takes 200 muscles to take a single step forward
#WalkToWorkDay

Join our EMIF project on 18 April in Brussels to discuss (re)using data for health research, incl. benefits & challenges, legal & ethical issues. More info & registration: https://t.co/wSQfhOtKta #Alzheimer #Obesity #GDPR #PatientsInvolved

Breaking news! #H2020 invests €13 million in 257 small and medium-sized companies (SMEs) across 31 countries to help them get their innovations to market quicker under the European Innovation Council pilot #EU_eic

⇢ https://t.co/XqjS9cPgcU

Chantal Mathieu presents #INNODIA at #DUKPC discussing the heterogeneity of #T1D and how to stop #type1diabetes progression #EUresearch #IMI2

Towards precision medicine in diabetes through public-private partnership @IMI_JU Look at this new stratification of diabetic patients Will pave the way to giving the right treatments to the right patients !

Load More...